Endoureterotomy
Endoureterotomy is an endoscopic treatment for ureteral stricture in which the narrowed ureter is incised full-thickness from within the lumen and then stented while the ureter heals in an expanded configuration. It is the main endoscopic alternative to formal reconstruction for benign strictures, but its durability depends heavily on stricture biology: short, partial, nonischemic strictures do well; long, obliterative, ischemic, radiation-related, or recurrent strictures should usually move toward reconstruction.[1][2][3][4]
This page covers endoscopic incision of ureteral strictures. For reconstructive alternatives, see Ureteroureterostomy, Ureteral Reimplantation, Buccal Mucosa Graft Ureteroplasty, and Upper Tract Reconstruction Principles. Endoscopic paclitaxel dilation is covered separately under Drug-Coated Balloon Therapy.
Core Principle
The operation releases the scar ring by making a longitudinal full-thickness incision through mucosa, muscularis, and adventitia until periureteral fat is seen.[5][6][7] A ureteral stent then splints the incised segment for roughly 4-8 weeks, allowing the lumen to re-epithelialize open rather than recontracting immediately.
The analogy is direct visual internal urethrotomy: both procedures are attractive because they are low morbidity, and both are vulnerable to recurrence when the stricture is long, ischemic, dense, or repeatedly treated.
Endopyelotomy is the same concept applied at the ureteropelvic junction (UPJ). It has a narrower role now that minimally invasive pyeloplasty is widely available.
Historical Development
| Era | Development | Relevance |
|---|---|---|
| Davis intubated ureterotomy | Open intubated ureterotomy concept | Established the principle that an incised ureter can heal over a splint |
| 1980s | Antegrade percutaneous endopyelotomy | Moved UPJ incision into the endoscopic era |
| 1992 | Meretyk, Clayman, and colleagues reported a dedicated endoureterotomy series | Early 62% success and the beginning of stricture-specific endoscopic series[5] |
| 1993 | Acucise cutting balloon introduced | Fluoroscopy-guided incision without direct visualization[8] |
| 1997 | Ho:YAG laser endoureterotomy series reported | Helped establish laser incision as the dominant modern technique[9] |
| Modern era | Laser incision plus selective balloon dilation, steroid injection, dual stents, or metallic stents | Attempts to improve an operation whose core limitation is restenosis biology[10][11][12][13] |
Approaches
| Approach | How It Is Done | Best Fit | Limitations |
|---|---|---|---|
| Retrograde ureteroscopic | Semirigid or flexible ureteroscope passed from bladder to stricture; incision under direct vision | Most native ureteral strictures; outpatient endoscopic workflow | Can be difficult across tight, proximal, or ureteroenteric strictures |
| Antegrade percutaneous | Nephrostomy access with antegrade ureteroscope/nephroscope | Proximal ureter, UPJ, transplant, or ureteroenteric strictures where retrograde access is poor | Requires percutaneous access and its morbidity |
| Combined antegrade-retrograde | Rendezvous access from both ends | Near-obliterative strictures where a wire cannot be passed safely | More complex; often a signal that reconstruction may be more durable |
| Acucise cutting balloon | Fluoroscopic balloon with electrocautery wire incises while inflated | Historical option for UPJ or ureteral strictures | No direct visualization, no biopsy, less control of incision depth; now largely replaced by laser[8][14][15] |
Energy Sources
| Energy Source | Mechanism | Advantages | Drawbacks |
|---|---|---|---|
| Ho:YAG laser | Pulsed photothermal incision at 2100 nm | Precise, hemostatic, works through small flexible scopes, current standard | Requires direct vision and endoscopic access[6][9] |
| Electrocautery / hot wire | Electrical tissue incision | Widely available; historical experience | Thermal spread and less precise control than laser |
| Cold knife | Mechanical incision | No thermal injury | Harder to use in small tortuous ureteral lumens |
| Acucise | Balloon-mounted electrocautery wire | Fast and fluoroscopy-guided | Blind incision, bleeding risk, no biopsy, largely historical[8][14] |
| Thulium fiber laser | Emerging photothermal laser platform | Potentially precise cutting | Limited ureteral endoureterotomy outcomes data |
Retrograde Laser Technique
- Cystoscopy and retrograde pyelography define stricture location, length, severity, and upstream dilation.
- Safety wire placement across the stricture is attempted. A completely impassable segment should prompt antegrade access, rendezvous strategy, or reconstruction rather than blind force.
- Ureteroscopy confirms the stricture endoscopically. Suspicious lesions should be biopsied before incision; malignant strictures are not endoureterotomy disease.
- Incision planning chooses a lateral or posterolateral line that avoids known vessels and maintains orientation.
- Laser incision is made with a small Ho:YAG fiber, commonly 200-365 microns, through the full scar thickness until periureteral fat is visible.[9][16]
- Balloon dilation may be added after incision, typically to open the released scar ring and confirm full expansion.[11][16]
- Adjunctive triamcinolone may be injected into the incised bed in selected recurrent, longer, or ureteroenteric strictures.[2][12]
- Stenting splints the incision. Standard double-J stents are common; larger-caliber endoureterotomy stents or dual ipsilateral stents have been used to increase luminal scaffolding.[2][13][17]
- Drainage and follow-up depend on approach and extravasation. Stents are usually removed after 4-8 weeks.
Incision Direction
At the UPJ, Sampaio and Favorito's vascular anatomy work supports avoiding deep anterior incision because prominent anterior vessels were common, while the posterior surface was often vessel-free only within a limited segment. A lateral incision is generally the safest practical rule.[18]
For mid- and distal-ureteral strictures, incision is usually lateral or posterolateral, away from medially located iliac and gonadal vessels. The exact line should follow intraoperative anatomy rather than a memorized clock face.
Patient Selection
Endoureterotomy is best framed as a selection-sensitive treatment, not as a universal stricture repair.
| Feature | Favors Endoureterotomy | Favors Reconstruction |
|---|---|---|
| Length | <=1-2 cm | >2 cm, especially >3 cm |
| Etiology | Nonischemic, stone-related, short iatrogenic narrowing | Radiation, devascularization, ureteroenteric ischemia, dense fibrosis |
| Lumen | Partial stricture; wire can pass | Obliterated or near-obliterated segment |
| Renal function | Preserved ipsilateral function, often >=25% | Poor function, severe chronic obstruction, nonfunctional unit |
| Prior treatment | First endoscopic attempt | Failed prior endoureterotomy or repeated dilation |
| Hydronephrosis | Mild or moderate | Severe chronic dilation |
| Patient priority | Lowest morbidity and accepts recurrence risk | Maximal durable patency |
Classic series repeatedly found worse outcomes with long strictures, ischemic strictures, compromised ipsilateral renal function, and ureteroenteric strictures.[1][2][3][4][19]
Outcomes: Native Benign Ureteral Strictures
| Series | N | Technique | Success | Key Lesson |
|---|---|---|---|---|
| Meretyk et al. | 13 | Endoureterotomy | 62% | Early dedicated series; steroid injection appeared promising[5] |
| Singal et al. | 22 | Ho:YAG laser | 76% | Length and etiology drove results[9] |
| Wolf et al. | 38 benign strictures | Mixed endoureterotomy | 80% 3-year success | Poor renal function and ureteroenteric strictures performed worse[2] |
| Richter et al. | 27 | Endoureterotomy | 89.5% with intact vascularity | Vascular compromise reduced success[19] |
| Razdan et al. | 50 | Ureteroscopic endoureterotomy | 74% | Strictures >2 cm did poorly; stent strategy mattered[3] |
| Gnessin et al. | 35 | Ho:YAG laser | 82% symptomatic; 78.7% radiographic | Nonischemic success 100% vs 64.7% ischemic[1] |
| Corcoran et al. | 34 | Ho:YAG plus balloon | 85% | Many patients required more than one endoscopic procedure[4] |
| Ou et al. | 95 endourologic treatments | Mixed endoscopic | 51.6% | Reconstruction was far more durable in the same institutional experience[10] |
The practical synthesis is that success can reach roughly 75-85% in carefully selected short nonischemic native strictures, but broader real-world cohorts fall lower when long, complex, ischemic, or recurrent strictures are included.
Ureteroenteric Anastomotic Strictures
Ureteroenteric anastomotic strictures are harder endoscopic targets because ischemia, scarring, prior diversion, and altered anatomy are common. Endoscopic treatment is often reasonable as a first attempt because morbidity is low, but open or robotic revision remains the durability benchmark.
| Series | Technique | Success | Note |
|---|---|---|---|
| Wolf et al. | Mixed endoureterotomy | 32% 3-year success | Markedly worse than benign native strictures[2] |
| Lin et al. | Acucise | 30% | Limited durability for ureteroenteric disease[20] |
| Touiti et al. | Acucise | 50-75% | Results varied by anastomotic site[15] |
| Laven et al. | Endoureterotomy vs open revision | 50% vs 80% | Open revision had better success[21] |
| Gomez et al. | First-line endourologic management | 71.4% | Supports an initial low-morbidity attempt in selected patients[22] |
| Katims et al. | Laser incision, triamcinolone, balloon dilation, parallel stents | 83.3% | Modern combination protocol with favorable intermediate results[12] |
Transplant and UPJ Settings
Transplant Ureteral Strictures
Transplant strictures are anatomically and biologically distinct. Gdor et al. reported successful Ho:YAG laser endoureterotomy in all 5 transplant-kidney strictures <=10 mm, while balloon dilation alone succeeded in only 1 of 3 patients in the same report.[23] These are small numbers, but they reinforce the general pattern: very short strictures are the best endoscopic candidates.
Endopyelotomy for UPJ Obstruction
Endopyelotomy has lower durability than pyeloplasty. A comparative effectiveness study found higher failure after endopyelotomy than open pyeloplasty, while minimally invasive pyeloplasty was more durable than endopyelotomy.[24] Contemporary review data place retrograde endopyelotomy success below pyeloplasty, with best results in short stenoses, modest hydronephrosis, preserved renal function, and no major crossing-vessel concern.[25][26]
In practical terms, endopyelotomy is now a selective option for favorable adult UPJ obstruction, failed patients who cannot tolerate reconstruction, or those prioritizing the lowest morbidity after counseling. Pyeloplasty remains the durability standard.
Adjunctive Measures
| Adjunct | Rationale | Evidence Signal |
|---|---|---|
| Balloon dilation after incision | Expands the released scar ring and confirms lumen caliber | Often combined with Ho:YAG incision; balloon-only long-term success is modest[11][27] |
| Triamcinolone injection | Reduces fibroblast proliferation and collagen deposition in the incised bed | Associated with better outcomes in some series; central to the Katims UEAS protocol[2][12] |
| Larger stents | Splint the incision more aggressively | Wolf et al. associated >=12F stenting with better results in strictures >1 cm[2] |
| Dual ipsilateral stents | Increase scaffold diameter without a custom endoureterotomy stent | Mohyelden et al. reported better long-term success with two 7F stents than one stent in bilharzial strictures[13] |
| Covered metallic stents | Longer-term internal scaffold for patients unfit for reconstruction or after endoscopic release | Allium and other covered stents show improving but still selective evidence[28][29][30] |
Metal stents should be understood as maintenance or salvage tools, not a simple replacement for reconstruction in healthy surgical candidates. A 2025 meta-analysis suggested better intermediate performance for Allium than several other segmental metallic stents, and a 310-case Allium series reported declining success over 3 years, underscoring the need for surveillance.[28][30]
Complications
| Complication | Comment |
|---|---|
| Extravasation / urinoma | Expected risk after full-thickness incision; usually managed with stenting, drainage, or nephrostomy if needed |
| Bleeding | More concerning with blind cutting-balloon incision; uncommon with controlled laser incision |
| UTI / fever | Treat with culture-directed antibiotics and ensure drainage |
| Ureteral perforation | Usually stented; risk rises with tight strictures and difficult access |
| Vascular injury | Rare but serious; incision direction matters, especially near the UPJ and iliac vessels |
| Recurrent stricture | Main long-term failure mode; recurrence risk depends on selection |
| Need for secondary procedure | Repeat endoscopy, chronic stent, nephrostomy, or definitive reconstruction may be required |
Timing of Failure and Follow-Up
Most failures declare themselves early. Gnessin et al. reported all failures within 9 months, and Wolf et al. observed no benign-stricture failures beyond 11 months.[1][2] That pattern supports close surveillance during the first postoperative year.
Typical follow-up includes:
- stent removal at 4-8 weeks,
- renal ultrasound or CT urogram after stent removal,
- functional drainage study when symptoms, renal function, or imaging are equivocal,
- low threshold for earlier imaging if flank pain, fever, rising creatinine, or recurrent hydronephrosis develops,
- continued longer-term surveillance for ureteroenteric, ischemic, transplant, or metal-stent cases.
Endoureterotomy vs Reconstruction
Endoureterotomy offers shorter operative time, less blood loss, faster recovery, and outpatient feasibility. Its cost is durability. Ou et al. found overall success of 51.6% for endourologic treatment compared with 95.7% for surgical reconstruction in benign ureteral strictures, with surgical method the key independent factor for success and recurrence.[10] Zi et al. similarly found that balloon dilation could approximate reconstructive approaches early but lost ground at 12 and 24 months.[31]
| Scenario | Usually Better Choice |
|---|---|
| Short (<=1-2 cm), benign, partial, nonischemic stricture | Endoureterotomy reasonable first |
| Long (>2 cm) proximal/mid stricture | BMG ureteroplasty, augmented anastomotic repair, appendix, or ileal substitution depending anatomy |
| Upper/mid complete transection or short excisable stricture | Ureteroureterostomy |
| Distal stricture | Ureteral reimplantation, psoas hitch, Boari flap, or selective non-transecting reimplant |
| Radiation-induced, ischemic, recurrent, or obliterated stricture | Reconstruction favored |
| Ureteroenteric anastomotic stricture | Endoscopic attempt is reasonable in selected cases; revision remains the durability standard |
| Poor operative candidate | Endoureterotomy, balloon dilation, chronic stent, nephrostomy, or metallic stent may be pragmatic |
Operative Pearls
- Confirm benign disease before incision; biopsy suspicious strictures.
- Do not force a wire through an obliterated segment; use antegrade/rendezvous access or reconstruct.
- Incise full-thickness until periureteral fat is seen; a shallow mucosal cut is just dilation with extra steps.
- Keep the incision lateral or posterolateral unless anatomy dictates otherwise.
- Counsel patients that low morbidity is paired with lower durability than reconstruction.
- Treat failure as useful information: recurrent narrowing after a proper endoureterotomy should usually trigger definitive reconstruction rather than serial incision.
- For ureteroenteric strictures, consider combination protocols: laser incision, balloon dilation, triamcinolone, and robust stenting.
- Preserve future reconstruction options by avoiding devascularizing or traumatic repeated instrumentation.
Summary
Endoureterotomy is a valuable minimally invasive option for short, benign, partial, nonischemic ureteral strictures with preserved renal function. Ho:YAG laser incision under direct vision is the modern standard, often combined with balloon dilation, steroid injection, and thoughtful stenting. The operation can achieve 75-85% success in favorable native strictures, but real-world durability is substantially lower than reconstruction when complex strictures are included. Its best role is therefore selective: first-line endoscopic management for favorable strictures, a low-morbidity first attempt for selected ureteroenteric anastomotic strictures, and a palliative or temporizing option for patients who are poor reconstructive candidates.
References
- Gnessin E, Yossepowitch O, Holland R, Livne PM, Lifshitz DA. Holmium laser endoureterotomy for benign ureteral stricture: a single center experience. J Urol. 2009;182(6):2775-2779. doi:10.1016/j.juro.2009.08.051.
- Wolf JS Jr, Elashry OM, Clayman RV. Long-term results of endoureterotomy for benign ureteral and ureteroenteric strictures. J Urol. 1997;158(3 Pt 1):759-764. doi:10.1097/00005392-199709000-00016.
- Razdan S, Silberstein IK, Bagley DH. Ureteroscopic endoureterotomy. BJU Int. 2005;95 Suppl 2:94-101. doi:10.1111/j.1464-410X.2005.05207.x.
- Corcoran AT, Smaldone MC, Ricchiuti DD, Averch TD. Management of benign ureteral strictures in the endoscopic era. J Endourol. 2009;23(11):1909-1912. doi:10.1089/end.2008.0453.
- Meretyk S, Albala DM, Clayman RV, Denstedt JD, Kavoussi LR. Endoureterotomy for treatment of ureteral strictures. J Urol. 1992;147(6):1502-1506. doi:10.1016/s0022-5347(17)37608-5.
- Emiliani E, Breda A. Laser endoureterotomy and endopyelotomy: an update. World J Urol. 2015;33(4):583-587. doi:10.1007/s00345-014-1405-3.
- Seseke F, Heuser M, Zoller G, Plothe KD, Ringert RH. Treatment of iatrogenic postoperative ureteral strictures with Acucise endoureterotomy. Eur Urol. 2002;42(4):370-375. doi:10.1016/s0302-2838(02)00322-6.
- Chandhoke PS, Clayman RV, Stone AM, et al. Endopyelotomy and endoureterotomy with the Acucise ureteral cutting balloon device: preliminary experience. J Endourol. 1993;7(1):45-51. doi:10.1089/end.1993.7.45.
- Singal RK, Denstedt JD, Razvi HA, Chun SS. Holmium:YAG laser endoureterotomy for treatment of ureteral stricture. Urology. 1997;50(6):875-880. doi:10.1016/S0090-4295(97)00511-6.
- Ou Y, Zhang G, Zhu X, et al. Evaluation of risk factors, treatment options, and prognostic-related factors in patients with benign ureteral strictures: an 8-year single-center experience. Int J Urol. 2023;30(10):847-852. doi:10.1111/iju.15211.
- Wang B, Gao W, Yang K, et al. Analysis of the efficacy and risk factors for failure of balloon dilation for benign ureteral stricture. J Clin Med. 2023;12(4):1655. doi:10.3390/jcm12041655.
- Katims AB, Edelblute BT, Tam AW, et al. Long-term outcomes of laser incision and triamcinolone injection for the management of ureteroenteric anastomotic strictures. J Endourol. 2021;35(1):21-24. doi:10.1089/end.2020.0593.
- Mohyelden K, Hussein HA, El Helaly HA, Ibrahem H, Abdelwahab H. Long-term outcomes of two ipsilateral double-J stents versus single double-J stent after laser endoureterotomy for bilharzial ureteral strictures. J Endourol. 2021;35(6):775-780. doi:10.1089/end.2020.0956.
- Cohen TD, Gross MB, Preminger GM. Long-term follow-up of Acucise incision of ureteropelvic junction obstruction and ureteral strictures. Urology. 1996;47(3):317-323. doi:10.1016/S0090-4295(99)80445-2.
- Touiti D, Gelet A, Deligne E, et al. Treatment of uretero-intestinal and ureterovesical strictures by Acucise balloon catheter. Eur Urol. 2002;42(1):49-54. doi:10.1016/s0302-2838(02)00070-2.
- Gao X, Chen J, Wang W, et al. Step-by-step technique for the endoscopic treatment of ureteric stricture. BJU Int. 2021;128(6):692-696. doi:10.1111/bju.15558.
- Gerber GS, Kim JC. Ureteroscopic endopyelotomy in the treatment of patients with ureteropelvic junction obstruction. Urology. 2000;55(2):198-202. doi:10.1016/s0090-4295(99)00530-0.
- Sampaio FJ, Favorito LA. Ureteropelvic junction stenosis: vascular anatomical background for endopyelotomy. J Urol. 1993;150(6):1787-1791. doi:10.1016/s0022-5347(17)35896-2.
- Richter F, Irwin RJ, Watson RA, Lang EK. Endourologic management of benign ureteral strictures with and without compromised vascular supply. Urology. 2000;55(5):652-657. doi:10.1016/s0090-4295(00)00484-2.
- Lin DW, Bush WH, Mayo ME. Endourological treatment of ureteroenteric strictures: efficacy of Acucise endoureterotomy. J Urol. 1999;162(3 Pt 1):696-698. doi:10.1097/00005392-199909010-00017.
- Laven BA, O'Connor RC, Gerber GS, Steinberg GD. Long-term results of endoureterotomy and open surgical revision for the management of ureteroenteric strictures after urinary diversion. J Urol. 2003;170(4 Pt 1):1226-1230. doi:10.1097/01.ju.0000086701.68756.8f.
- Gomez FD, Thomas A, Sempels M, et al. Outcomes following first-line endourologic management of ureteroenteric anastomotic strictures after urinary diversion: a single-center study. Urology. 2017;102:38-42. doi:10.1016/j.urology.2016.10.009.
- Gdor Y, Gabr AH, Faerber GJ, Wolf JS Jr. Holmium:yttrium-aluminum-garnet laser endoureterotomy for the treatment of transplant kidney ureteral strictures. Transplantation. 2008;85(9):1318-1321. doi:10.1097/TP.0b013e31816c7f19.
- Jacobs BL, Lai JC, Seelam R, et al. The comparative effectiveness of treatments for ureteropelvic junction obstruction. Urology. 2018;111:72-77. doi:10.1016/j.urology.2017.09.002.
- Kolvatzis M, Corrales M, Moretto S, Quara A, Traxer O. Long-term results of retrograde endopyelotomy: a narrative review. World J Urol. 2025;43(1):260. doi:10.1007/s00345-025-05618-0.
- Khan F, Ahmed K, Lee N, et al. Management of ureteropelvic junction obstruction in adults. Nat Rev Urol. 2014;11(11):629-638. doi:10.1038/nrurol.2014.240.
- Lu C, Zhang W, Peng Y, et al. Endoscopic balloon dilatation in the treatment of benign ureteral strictures: a meta-analysis and systematic review. J Endourol. 2019;33(4):255-262. doi:10.1089/end.2018.0797.
- Bian X, Hu H, Tian C, et al. Comparison of different segmental metal ureteral stents as maintenance therapy across different years in ureteral stricture management: a systematic review and meta-analysis. Int J Surg. 2025;111(7):4746-4755. doi:10.1097/JS9.0000000000002384.
- Kowalski F, Kuffel B, Pozniak M, et al. Endourological treatment of ureteral strictures with the use of self-expanding stents: is it possible to completely cure the stricture endoscopically? A report on the experience with implantation of 35 stents with a two-year follow-up period; a retrospective study. World J Urol. 2025;43(1):201. doi:10.1007/s00345-025-05574-9.
- Gao X, Chen J, Chen G, et al. Self-expanding metal ureteral stent for treating ureteral strictures: three-year follow-up results from 310 cases. Int J Surg. 2025;111(8):4986-4992. doi:10.1097/JS9.0000000000002578.
- Zi D, Cao W, Chen F, Zhu L. Management for benign ureteral stricture: comparison of robot-assisted laparoscopy, conventional laparoscopy, and balloon dilation. J Endourol. 2023;37(8):868-875. doi:10.1089/end.2023.0047.